Hypoxia-inducible factor 1: A new hope to counteract neurodegeneration?

Journal of Neurochemistry

Volumn 112, Issue 1, 2010, Pages 1-12

  Correia, Sónia C ^a,b   Moreira, Paula I ^a,c  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Alzheimer's disease; Cerebral ischemic stroke; Huntington's disease; Hypoxia inducible factor 1; Neuroprotection; Parkinson's disease

Indexed keywords

2 METHOXYESTRADIOL; ADENOVIRUS VECTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; CLIOQUINOL; COBALT CHLORIDE; DEFEROXAMINE; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; MIMOSINE; PROTOCATECHUIC ACID; REACTIVE OXYGEN METABOLITE; RECOMBINANT ERYTHROPOIETIN; UBIQUINONE;

ALZHEIMER DISEASE; ANGIOGENESIS; APOPTOSIS; BRAIN HYPOXIA; BRAIN ISCHEMIA; CELL SURVIVAL; CEREBROVASCULAR ACCIDENT; DEGENERATIVE DISEASE; DETERIORATION; DRUG TARGETING; GENE EXPRESSION; GLYCOLYSIS; HUMAN; HUNTINGTON CHOREA; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXYGEN TRANSPORT; PARKINSON DISEASE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

ANIMALS; ANOXIA; DRUG DELIVERY SYSTEMS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; NERVE DEGENERATION; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; SIGNAL TRANSDUCTION;

EID: 71649085107     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06443.x     Document Type: Review

References (144)

1. Agani F. H., Pichiule P., Chavez J. C. LaManna J. C. (2000) The role of mitochondria in the regulation of hypoxia-inducible factor 1 expression during hypoxia. J. Biol. Chem. 275, 35863 35867.
2. Atwood C. S., Scarpa R. C., Huang X., Moir R. D., Jones W. D., Fairlie D. P., Tanzi R. E. Bush A. I. (2000) Characterization of copper interactions with Alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42. J. Neurochem. 75, 1219 1233. Available at: http://www.strokecenter.org/patients/stats.htm.
3. Baranova O., Miranda L. F., Pichiule P., Dragatsis I., Johnson R. S. Chavez J. C. (2007) Neuron-specific inactivation of the hypoxia inducible factor 1alpha increases brain injury in a mouse model of transient focal cerebral ischemia. J. Neurosci. 27, 6320 6332.
4. Beal M. F. (2003) Mitochondria, oxidative damage, and inflammation in Parkinson's disease. Ann. N.Y. Acad. Sci. 991, 120 131.
5. Beal M. F., Brouillet E., Jenkins B. G. et al. (1993) Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J. Neurosci. 13, 4181 4192.
6. Bell E. L., Klimova T. A., Eisenbart J., Moraes C. T., Murphy M. P., Budinger G. R. Chandel N. S. (2007) The Qo site of the mitochondrial complex III is required for the transduction of hypoxic signaling via reactive oxygen species production. J. Cell Biol. 177, 1029 1036.
7. Ben-Shachar D., Eshel G., Finberg J. P. Youdim M. B. (1991) The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons. J. Neurochem. 56, 1441 1444.
8. Bergeron M., Yu A. Y., Solway K. E., Semenza G. L. Sharp F. R. (1999) Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain. Eur. J. Neurosci. 11, 4159 4170.
9. Bergeron M., Gidday J. M., Yu A. Y., Semenza G. L., Ferriero D. M. Sharp F. R. (2000) Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain. Ann. Neurol. 48, 285 296.
10. Bernaudin M., Marti H. H., Roussel S., Divoux D., Nouvelot A., MacKenzie E. T. Petit E. (1999) A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 19, 643 651.
11. Bhattacharya S., Michels C. L., Leung M. K., Arany Z. P., Kung A. L. Livingston D. M. (1999) Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1. Genes Dev. 13, 64 75.
12. Bishop G. M., Robinson S. R., Liu Q., Perry G., Atwood C. S. Smith M. A. (2002) Iron: a pathological mediator of Alzheimer disease? Dev. Neurosci. 24, 184 187.
13. Bruick R. K. (2000) Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc. Natl Acad. Sci. USA 97, 9082 9087.
14. Brunelle J. K., Bell E. L., Quesada N. M., Vercauteren K., Tiranti V., Zeviani M., Scarpulla R. C. Chandel N. S. (2005) Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. Cell Metab. 1, 409 414.
15. Cardoso S. M., Moreira P. I., Agostinho P., Pereira C. Oliveira C. R. (2005) Neurodegenerative pathways in Parkinson's disease: therapeutic strategies. Curr. Drug Targets CNS Neurol. Disord. 4, 405 419.
16. Carrero P., Okamoto K., Coumailleau P., O'Brien S., Tanaka H. Poellinger L. (2000) Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1alpha. Mol. Cell. Biol. 20, 402 415.
17. Chandel N. S., Maltepe E., Goldwasser E., Mathieu C. E., Simon M. C. Schumacker P. T. (1998) Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc. Natl Acad. Sci. USA 95, 11715 11720.
18. 2 sensing. J. Biol. Chem. 275, 25130 25138.
19. Chang S., Jiang X., Zhao C., Lee C. Ferriero D. M. (2008) Exogenous low dose hydrogen peroxide increases hypoxia-inducible factor-1alpha protein expression and induces preconditioning protection against ischemia in primary cortical neurons. Neurosci. Lett. 441, 134 138.
20. Chavez J. C., Agani F., Pichiule P. LaManna J. C. (2000) Expression of hypoxia-inducible factor-1ain the brain of rats during chronic hypoxia. J. Appl. Physiol. 89, 1937 1942.
21. Cherny R. A., Atwood C. S., Xilinas M. E. et al. (2001) Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron 30, 665 676.
22. Crapper McLachlan D. R., Dalton A. J., Kruck T. P., Bell M. Y., Smith W. L., Kalow W. Andrews D. F. (1991) Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet 337, 1304 1308.
23. DeHaan C., Habibi-Nazhad B., Yan E., Salloum N., Parliament M. Allalunis-Turner J. (2004) Mutation in mitochondrial complex I ND6 subunit is associated with defective response to hypoxia in human glioma cells. Mol. Cancer 3, 19.
24. Demougeot C., Bobillier-Chaumont S., Mossiat C., Marie C. Berthelot A. (2004a) Effect of diets with different magnesium content in ischemic stroke rats. Neurosci. Lett. 362, 17 20.
25. Demougeot C., Van Hoecke M., Bertrand N., Prigent-Tessier A., Mossiat C., Beley A. Marie C. (2004b) Cytoprotective efficacy and mechanisms of the liposoluble iron chelator 2,2′-dipyridyl in the rat photothrombotic ischemic stroke model. J. Pharmacol. Exp. Ther. 311, 1080 1087.
26. Ebert B. L., Firth J. D. Ratcliffe P. J. (1995) Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct Cis-acting sequences. J. Biol. Chem. 270, 29083 29089.
27. Ehrenreich H., Hasselblatt M., Dembowski C. et al. (2002) Erythropoietin therapy for acute stroke is both safe and beneficial. Mol. Med. 8, 495 505.
28. Feldser D., Agani F., Iyer N. V., Pak B., Ferreira G. Semenza G. L. (1999) Reciprocal positive regulation of hypoxia-inducible factor 1a and insulin-like growth factor 2. Cancer Res. 59, 3915 3918.
29. Forsythe J. A., Jiang B. H., Iyer N. V., Agani F., Leung S. W., Koos R. D. Semenza G. L. (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16, 4604 4613.
30. Freeman R. S. Barone M. C. (2005) Targeting hypoxia-inducible factor (HIF) as a therapeutic strategy for CNS disorders. Curr. Drug Targets CNS Neurol. Disord. 4, 85 92.
31. Freret T., Valable S., Chazalviel L., Saulnier R., Mackenzie E. T., Petit E., Bernaudin M., Boulouard M. Schumann-Bard P. (2006) Delayed administration of deferoxamine reduces brain damage and promotes functional recovery after transient focal cerebral ischemia in the rat. Eur. J. Neurosci. 23, 1757 1765.
32. Furuichi T., Liu W., Shi H., Miyake M. Liu K. J. (2005) Generation of hydrogen peroxide during brief oxygen-glucose deprivation induces preconditioning neuronal protection in primary cultured neurons. J. Neurosci. Res. 79, 816 824.
33. Gerber H. P., Condorelli F., Park J. Ferrara N. (1997) Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. J. Biol. Chem. 272, 23659 23667.
34. Graven K. K., Yu Q., Pan D., Roncarati J. S. Farber H. W. (1999) Identification of an oxygen responsive enhancer element in the glyceraldehyde-3-phosphate dehydrogenase gene. Biochim. Biophys. Acta 1447, 208 218.
35. Greenfield J. P., Gross R. S., Gouras G. K. Xu H. (2000) Cellular and molecular basis of beta-amyloid precursor protein metabolism. Front. Biosci. 5, 72 83.
36. Guo S., Miyake M., Liu K. J. Shi H. (2009) Specific inhibition of hypoxia inducible factor 1 exaggerates cell injury induced by in vitro ischemia through deteriorating cellular redox environment. J. Neurochem. 108, 1309 1321.
37. Guzy R. D., Hoyos B., Robin E., Chen H., Liu L., Mansfield K. D., Simon M. C., Hammerling U. Schumacker P. T. (2005) Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab. 1, 401 408.
38. Hamrick S. E., McQuillen P. S., Jiang X., Mu D., Madan A. Ferriero D. M. (2005) A role for hypoxia-inducible factor-1alpha in desferoxamine neuroprotection. Neurosci. Lett. 379, 96 100.
39. Hanson L., Roeytenberg A., Martinez P. M. et al. (2009) Intranasal deferoxamine provides increased brain exposure and significant protection in rat ischemic stroke. J. Pharmacol. Exp. Ther. 330, 679 686.
40. Hewitson K. S., McNeill L. A., Riordan M. V. et al. (2002) Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J. Biol. Chem. 277, 26351 26355.
41. Hoyer S. (2004) Causes and consequences of disturbances of cerebral glucose metabolism in sporadic Alzheimer disease: therapeutic implications. Adv. Exp. Med. Biol. 541, 135 152.
42. Huang L. E., Arany Z., Livingston D. M. Bunn H. F. (1996) Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its a subunit. J. Biol. Chem. 271, 32253 32259.
43. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl Acad. Sci. USA 95, 7987 7992.
44. 2 sensing. Science 292, 464 468.
45. 2-regulated prolyl hydroxylation. Science 292, 468 472.
46. Jiang B. H., Semenza G. L., Bauer C. Marti H. H. (1996) Hypoxia-inducible factor 1 levels vary exponentially over a physiologically. Am. J. Physiol. 271, 1172 1180.
47. Jin K. L., Mao X. O. Greenberg D. A. (2000) Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. Proc. Natl Acad. Sci. USA 97, 10242 10247.
48. Kaluz S., Kaluzová M., Chrastina A., Olive P. L., Pastoreková S., Pastorek J., Lerman M. I. Stanbridge E. J. (2002) Lowered oxygen tension induces expression of the hypoxia marker MN/carbonic anhydrase IX in the absence of hypoxia-inducible factor 1astabilization: a role for phosphatidylinositol 3′-kinase. Cancer Res. 62, 4469 4477.
49. Kaur D., Yantiri F., Rajagopalan S. et al. (2003) Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease. Neuron 37, 899 909.
50. Klimova T. Chandel N. S. (2008) Mitochondrial complex III regulates hypoxic activation of HIF. Cell Death Differ. 15, 660 666.
51. Koivunen P., Hirsila M., Gunzler V., Kivirikko K. I. Myllyharju J. (2004) Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases. J. Biol. Chem. 279, 9899 9904.
52. Kung A. L., Wang S., Klco J. M., Kaelin W. G. Livingston D. M. (2000) Suppression of tumor growth through disruption of hypoxia-inducible transcription. Nat. Med. 6, 1335 1340.
53. Kuroki M., Voest E. E., Amano S. et al. (1996) Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J. Clin. Invest. 98, 1667 1675.
54. Lan J. Jiang D. H. (1997) Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice. J. Neural Transm. 104, 469 481.
55. Lando D., Peet D. J., Gorman J. J., Whelan D. A., Whitelaw M. L. Bruick R. K. (2002) FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 16, 1466 1471.
56. Larsson E., Nanobashvili A., Kokaia Z. Lindvall O. (1999) Evidence for neuroprotective effects of endogenous brain-derived neurotrophic factor after global forebrain ischemia in rats. J. Cereb. Blood Flow Metab. 19, 1220 1228.
57. Lee P. J., Jiang B. H., Chin B. Y., Iyer N. V., Alam J., Semenza G. L. Choi A. M. (1997) Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J. Biol. Chem. 272, 5375 5381.
58. Lee C., Kim S. J., Jeong D. G., Lee S. M. Ryu S. E. (2003) Structure of human FIH-1 reveals a unique active site pocket and interaction sites for HIF-1 and von Hippel-Lindau. J. Biol. Chem. 278, 7558 7563.
59. Lee D. W., Rajagopalan S., Siddiq A., Gwiazda R., Yang L., Beal M. F., Ratan R. R. Andersen J. K. 2009) Inhibition of prolyl hydroxylase protects against MPTP-induced neurotoxicity: model for the potential involvement of the hypoxia-inducible factor pathway in Parkinson's disease. J. Biol. Chem. 284, 29065 29076.
60. Li J., Zhang X., Sejas D. P., Bagby G. C. Pang Q. (2004) Hypoxia-induced nucleophosmin protects cell death through inhibition of p53. J. Biol. Chem. 279, 41275 41279.
61. Li X., Lu F., Wang J. Z. Gong C. X. (2006) Concurrent alterations of O-GlcNAcylation and phosphorylation of tau in mouse brains during fasting. Eur. J. Neurosci. 23, 2078 2086.
62. Li Y. X., Ding S. J., Xiao L., Guo W. Zhan Q. (2008) Desferoxamine preconditioning protects against cerebral ischemia in rats by inducing expressions of hypoxia inducible factor 1 alpha and erythropoietin. Neurosci. Bull. 24, 89 95.
63. Li Y., Lim S., Hoffman D., Aspenstrom P., Federoff H. J. Rempe D. A. (2009) HUMMR, a hypoxia-and HIF-1alpha-inducible protein, alters mitochondrial distribution and transport. J. Cell Biol. 185, 1065 1081.
64. de Lima M. N., Dias C. P., Torres J. P. et al. (2008) Reversion of age-related recognition memory impairment by iron chelation in rats. Neurobiol. Aging 29, 1052 1059.
65. Lin M. T. Beal M. F. (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443, 787 795.
66. Liu F., Iqbal K., Grundke-Iqbal I., Hart G. W. Gong C. X. (2004) O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease. Proc. Natl Acad. Sci. USA 101, 10804 10809.
67. Liu J., Narasimhan P., Yu F. Chan P. H. (2005) Neuroprotection by hypoxic preconditioning involves oxidative stress-mediated expression of hypoxia-inducible factor and erythropoietin. Stroke 36, 1264 1269.
68. Liu Y., Liu F., Iqbal K., Grundke-Iqbal I. Gong C. X. (2008) Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease. FEBS Lett. 582, 359 364.
69. Lo E. H., Dalkara T. Moskowitz M. A. (2003) Mechanisms, challenges and opportunities in stroke. Nat. Rev. Neurosci. 4, 399 415.
70. Mahon P. C., Hirota K. Semenza G. L. (2001) FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev. 15, 2675 2686.
71. Mansfield K. D., Guzy R. D., Pan Y., Young R. M., Cash T. P., Schumacker P. T. Simon M. C. (2005) Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-α activation. Cell Metab. 1, 393 399.
72. Marti H. J., Bernaudin M., Bellail A., Schoch H., Euler M., Petit E. Risau W. (2000) Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am. J. Pathol. 156, 965 976.
73. Maxwell P. H., Wiesener M. S., Chang G. W. et al. (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399, 271 275.
74. McNeill L. A., Hewitson K. S., Claridge T. D., Seibel J. F., Horsfall L. E. Schofield C. J. (2002) Hypoxia-inducible factor asparaginyl hydroxylase (FIH-1) catalyses hydroxylation at the beta-carbon of asparagine-803. Biochem. J. 367, 571 575.
75. Migliore L. Coppedè F. (2009) Environmental-induced oxidative stress in neurodegenerative disorders and aging. Mutat. Res. 674, 73 84.
76. Mole D. R., Maxwell P. H., Pugh C. W. Ratcliffe P. J. (2001) Regulation of HIF by the von Hippel-Lindau tumour suppressor: implications for cellular oxygen sensing. IUBMB Life 52, 43 47.
77. Moreira P. I., Cardoso S. M., Santos M. S. Oliveira C. R. (2006a) The key role of mitochondria in Alzheimer's disease. J. Alzheimers Dis. 9, 101 110.
78. Moreira P. I., Honda K., Zhu X., Nunomura A., Casadesus G., Smith M. A. Perry G. (2006b) Brain and brawn: parallels in oxidative strength. Neurology 66, 97 101.
79. Moreira P. I., Zhu X., Lee H. G., Honda K., Smith M. A. Perry G. (2006c) The (un)balance between metabolic and oxidative abnormalities and cellular compensatory responses in Alzheimer disease. Mech. Ageing Dev. 127, 501 506.
80. Moreira P. I., Santos M. S. Oliveira C. R. (2007) Alzheimer's disease: a lesson from mitochondrial dysfunction. Antioxid. Redox Signal. 9, 1621 1630.
81. Moreira P. I., Duarte A. I., Santos M. S., Rego A. C. Oliveira C. R. (2009) An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer's disease. J. Alzheimers Dis. 16, 741 761.
82. Mu D., Chang Y. S., Vexler Z. S. Ferriero D. M. (2005) Hypoxia-inducible factor 1alpha and erythropoietin upregulation with deferoxamine salvage after neonatal stroke. Exp. Neurol. 195, 407 415.
83. Mukhopadhyay C. K., Mazumder B. Fox P. L. (2000) Role of hypoxia-inducible factor-1 in transcriptional activation of ceruloplasmin by iron deficiency. J. Biol. Chem. 275, 21048 21054.
84. zur Nedden S., Tomaselli B. Baier-Bitterlich G. (2008) HIF-1 alpha is an essential effector for purine nucleoside-mediated neuroprotection against hypoxia in PC12 cells and primary cerebellar granule neurons. J. Neurochem. 105, 1901 1914.
85. Nguyen T., Hamby A. Massa S. M. (2005) Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model. Proc. Natl Acad. Sci. USA 102, 11840 11845.
86. Nunomura A., Moreira P. I., Lee H. G., Zhu X., Castellani R. J., Smith M. A. Perry G. (2007) Neuronal death and survival under oxidative stress in Alzheimer and Parkinson diseases. CNS Neurol. Disord. Drug Targets 6, 411 423.
87. O'Rourke J. F., Pugh C. W., Bartlett S. M. Ratcliffe P. J. (1996) Identification of hypoxically inducible mRNAs in HeLa cells using differential-display PCR. Role of hypoxia-inducible factor-1. Eur. J. Biochem. 241, 403 410.
88. Palmer C., Roberts R. L. Bero C. (1994) Deferoxamine posttreatment reduces ischemic brain injury in neonatal rats. Stroke 25, 1039 1045.
89. Palmer L. A., Semenza G. L., Stoler M. H. Johns R. A. (1998) Hypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF-1. Am. J. Physiol. 274, 212 219.
90. Panov A. V., Gutekunst C. A., Leavitt B. R., Hayden M. R., Burke J. R., Strittmatter W. J. Greenamyre J. T. (2002) Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. Nat. Neurosci. 5, 731 736.
91. Pialoux V., Mounier R., Brown A. D., Steinback C. D., Rawling J. M. Poulin M. J. (2009) Relationship between oxidative stress and HIF-1 alpha mRNA during sustained hypoxia in humans. Free Radic. Biol. Med. 46, 321 326.
92. Piret J. P., Lecocq C., Toffoli S., Ninane N., Raes M. Michiels C. (2004) Hypoxia and CoCl2 protect HepG2 cells against serum deprivation-and t-BHP-induced apoptosis: a possible anti-apoptotic role for HIF-1. Exp. Cell Res. 295, 340 349.
93. Prass K., Ruscher K., Karsch M., Isaev N., Megow D., Priller J., Scharff A., Dirnagl U. Meisel A. (2002) Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro. J. Cereb. Blood Flow Metab. 22, 520 525.
94. Przedborski S., Vial M. Jackson-Lewis V. (2003) Neurodegeneration: what is it and where are we? J. Clin. Invest. 111, 3 10.
95. Pugh C. W., O'Rourke J. F., Nagao M., Gleadle J. M. Ratcliffe P. J. (1997) Activation of hypoxia-inducible factor-1; definition of regulatory domains within the alpha subunit. J. Biol. Chem. 272, 11205 11214.
96. Rami A., Bechmann I. Stehle J. H. (2008) Exploiting endogenous anti-apoptotic proteins for novel therapeutic strategies in cerebral ischemia. Prog. Neurobiol. 85, 273 296.
97. Ravati A., Ahlemeyer B., Becker A. Krieglstein J. (2000) Preconditioning-induced neuroprotection is mediated by reactive oxygen species. Brain Res. 866, 23 32.
98. Ritchie C. W., Bush A. I., Mackinnon A. et al. (2003) Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Arch. Neurol. 60, 1685 1691.
99. Ross C. A., Becher M. W., Colomer V., Engelender S., Wood J. D. Sharp A. H. (1997) Huntington's disease and dentatorubral-pallidoluysian atrophy: proteins, pathogenesis and pathology. Brain Pathol. 7, 1003 1016.
100. Rottkamp C. A., Raina A. K., Zhu X., Gaier E., Bush A. I., Atwood C. S., Chevion M., Perry G. Smith M. A. (2001) Redox-active iron mediates amyloid-beta toxicity. Free Radic. Biol. Med. 30, 447 450.
101. Ruscher K., Isaev N., Trendelenburg G., Weih M., Iurato L., Meisel A. Dirnagl U. (1998) Induction of hypoxia inducible factor 1 by oxygen glucose deprivation is attenuated by hypoxic preconditioning in rat cultured neurons. Neurosci. Lett. 254, 117 120.
102. Sadamoto Y., Igase K., Sakanaka M., Sato K., Otsuka H., Sakaki S., Masuda S. Sasaki R. (1998) Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery. Biochem. Biophys. Res. Commun. 253, 26 32.
103. Safran M. Kaelin W. G. Jr. (2003) HIF hydroxylation and the mammalian oxygen-sensing pathway. J. Clin. Investig. 111, 779 783.
104. Sakanaka M., Wen T. C., Matsuda S., Masuda S., Morishita E., Nagao M. Sasaki R. (1998) In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc. Natl Acad. Sci. USA 95, 4635 4640.
105. Salceda S. Caro J. (1997) Hypoxia-inducible factor 1α (HIF-1α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. J. Biol. Chem. 272, 22642 22647.
106. Sanjuán-Pla A., Cervera A. M., Apostolova N., Garcia-Bou R., Victor V. M., Murphy M. P. McCreath K. J. (2005) A targeted antioxidant reveals the importance of mitochondrial reactive oxygen species in the hypoxic signaling of HIF-1alpha. FEBS Lett. 579, 2669 2674.
107. Sasabe E., Tatemoto Y., Li D., Yamamoto T. Osaki T. (2005) Mechanism of HIF-1alpha-dependent suppression of hypoxia-induced apoptosis in squamous cell carcinoma cells. Cancer Sci. 96, 394 402.
108. Sayre L. M., Moreira P. I., Smith M. A. Perry G. (2005) Metal ions and oxidative protein modification in neurological disease. Ann. Ist. Super. Sanita. 41, 143 164.
109. Schabitz W. R., Schwab S., Spranger M. Hacke W. (1997) Intraventricular brain-derived neurotrophic factor reduces infarct size after focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 17, 500 506.
110. Schabitz W. R., Sommer C., Zoder W., Kiessling M., Schwaninger M. Schwab S. (2000) Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia. Stroke 31, 2212 2217.
111. Scheepers A., Joost H. G. Schurmann A. (2004) The glucose transporter families SGLT and GLUT: molecular basis of normal and aberrant function. J. Parenter. Enteral Nutr. 28, 364 371.
112. Schubert D., Soucek T. Blouw B. (2009) The induction of HIF-1 reduces astrocyte activation by amyloid beta peptide. Eur. J. Neurosci. 29, 1323 1334.
113. Selkoe D. J. (2001) Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. J. Alzheimers Dis. 3, 75 80.
114. 2 homeostasis by hypoxia-inducible factor 1. Annu. Rev. Cell Dev. Biol. 15, 551 578.
115. Semenza G. L. (2000a) HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J. Appl. Physiol. 88, 1474 1480.
116. Semenza G. L. (2000b) Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor 1. J. Clin. Invest. 106, 809 812.
117. Semenza G. L. (2002) Signal transduction to hypoxia-inducible factor 1. Biochem. Pharmacol. 64, 993 998.
118. Semenza G. L., Roth P. H., Fang H. M. Wang G. L. (1994) Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem. 269, 23757 23763.
119. Sharp F. R. Bernaudin M. (2004) HIF1 and oxygen sensing in the brain. Nat. Rev. Neurosci. 5, 437 448.
120. Sharp F. R., Bergeron M. Bernaudin M. (2001) Hypoxia-inducible factor in brain. Adv. Exp. Med. Biol. 502, 273 291.
121. Sharp F. R., Ran R., Lu A., Tang Y., Strauss K. I., Glass T., Ardizzone T. Bernaudin M. (2004) Hypoxic preconditioning protects against ischemic brain injury. NeuroRx 1, 26 35.
122. Shi Q., Zhang P., Zhang J., Chen X., Lu H., Tian Y., Parker T. L. Liu Y. 2009) Adenovirus-mediated brain-derived neurotrophic factor expression regulated by hypoxia response element protects brain from injury of transient middle cerebral artery occlusion in mice. Neurosci. Lett. 465, 220 225.
123. Siddiq A., Ayoub I. A., Chavez J. C. et al. (2005) Hypoxia-inducible factor prolyl 4-hydroxylase inhibition. A target for neuroprotection in the central nervous system. J. Biol. Chem. 280, 41732 41743.
124. Siddiq A., Aminova L. R. Ratan R. R. (2008) Prolyl 4-hydroxylase activity-responsive transcription factors: from hydroxylation to gene expression and neuroprotection. Front. Biosci. 13, 2875 2887.
125. Sirén A. L., Fratelli M., Brines M. et al. (2001) Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc. Natl Acad. Sci. USA 98, 4044 4049.
126. Sofic E., Riederer P., Heinsen H., Beckmann H., Reynolds G. P., Hebenstreit G. Youdim M. B. (1988) Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. J. Neural Transm. 74, 199 205.
127. Soucek T., Cumming R., Dargusch R., Maher P. Schubert D. (2003) The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide. Neuron 39, 43 56.
128. Sowter H. M., Ratcliffe P. J., Watson P., Greenberg A. H. Harris A. L. (2001) HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Cancer Res. 61, 6669 6673.
129. Srinivas V., Leshchinsky I., Sang N., King M. P., Minchenko A. Caro J. (2001) Oxygen sensing and HIF-1 activation does not require an active mitochondrial respiratory chain electron-transfer pathway. J. Biol. Chem. 276, 21995 21998.
130. Tabrizi S. J., Workman J., Hart P. E., Mangiarini L., Mahal A., Bates G., Cooper J. M. Schapira A. H. (2000) Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse. Ann. Neurol. 47, 80 86.
131. Tacchini L., Bianchi L., Bernelli-Zazzera A. Cairo G. (1999) Transferrin receptor induction by hypoxia. HIF-1-mediated transcriptional activation and cell-specific post-transcriptional regulation. J. Biol. Chem. 274, 24142 24146.
132. Takahashi Y., Takahashi S., Shiga Y., Yoshimi T. Miura T. (2000) Hypoxic induction of prolyl 4-hydroxylase a(I) in cultured cells. J. Biol. Chem. 275, 14139 14146.
133. Tazuke S. I., Mazure N. M., Sugawara J. et al. (1998) Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) gene expression in HepG2 cells: a possible model for IGFBP-1 expression in fetal hypoxia. Proc. Natl Acad. Sci. USA 95, 10188 10193.
134. Tupitsyna T. V., Slominskiì P. A., Shadrina M. I., Shetova I. M., Skvortsova V. I. Limborskaia S. A. (2006) Association of the IVS9-675C>A polymorphism of the HIF-1alpha gene with acute ischemic stroke in the Moscow population. Genetika 42, 858 861.
135. Vaux E. C., Metzen E., Yeates K. M. Ratcliffe P. J. (2001) Regulation of hypoxia-inducible factor is preserved in the absence of a functioning mitochondrial respiratory chain. Blood 98, 296 302.
136. Wang G. L. Semenza G. L. (1993) Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J. Biol. Chem. 268, 21513 21518.
137. 2 tension. Proc. Natl Acad. Sci. USA 92, 5510 5514.
138. Yang Y. T., Ju T. C. Yang D. I. (2005) Induction of hypoxia inducible factor-1 attenuates metabolic insults induced by 3-nitropropionic acid in rat C6 glioma cells. J. Neurochem. 93, 513 525.
139. Youdim M. B., Ben-Shacher D. Reiderer P. (1993) The possible role of iron in the etiopathology of Parkinson's disease. Mov. Disord. 8, 1 12.
140. Zaman K., Ryu H., Hall D. et al. (1999) Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, p21 (waf1/cip1), and erythropoietin. J. Neurosci. 19, 9821 9830.
141. Zecca L., Youdim M. B., Riederer P., Connor J. R. Crichton R. R. (2004) Iron, brain ageing and neurodegenerative disorders. Nat. Rev. Neurosci. 5, 863 873.
142. Zhang D. X. Gutterman D. D. (2007) Mitochondrial reactive oxygen species-mediated signaling in endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 292, 2023 2031.
143. Zhou D., Matchett G. A., Jadhav V., Dach N. Zhang J. H. (2008) The effect of 2-methoxyestradiol, a HIF-1alpha inhibitor, in global cerebral ischemia in rats. Neurol. Res. 30, 268 271.
144. Zipp F. Aktas O. (2006) The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases. Trends Neurosci. 29, 518 527.